RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 535 - per page Next page
Order by
An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More
Lotuzol is a new herbal drug composing water extract powder of Nelumbinis Semen to treat depression without sexual dysfunction, a major adverse effect in commonly used anti-depressants. More
A DNA microarray that becomes a protein microarray on demand and provides an efficient systematic approach to the study of protein interactions and drug target identification and validation. More
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
A method for high-throughput screening of known pathogenic viruses along with identification of "new" disease-associated viruses More
Identification of three genetic markers in the ABCB1 gene that can be used to predict the degree of neutropenia and peripheral neuropathy that an individual will experience following paclitaxel treatment More
This technology describes several antibodies, both polyclonal and monoclonal, to the prolactin receptor. More
This waveguide provides a significantly higher laser power delivery capability and higher damage threshold. More
This new technology is designed to screen for the autoantibodies for a spectrum of secreted tumor antigens in a single assay. More
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
Displaying 1..10 of 535 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us